Kala Bio Inc (KALA)
6.60
-0.13
(-1.93%)
USD |
NASDAQ |
May 20, 16:00
6.60
0.00 (0.00%)
After-Hours: 20:00
Kala Bio Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 97.38% |
| June 30, 2022 | 15.52% |
| March 31, 2022 | 43.51% |
| December 31, 2021 | 23.60% |
| September 30, 2021 | 70.39% |
| June 30, 2021 | 66.70% |
| March 31, 2021 | 76.88% |
| December 31, 2020 | 39.28% |
| Date | Value |
|---|---|
| September 30, 2020 | 68.42% |
| June 30, 2020 | 8.88% |
| March 31, 2020 | 66.95% |
| December 31, 2019 | 36.69% |
| September 30, 2019 | 53.96% |
| June 30, 2019 | 82.89% |
| March 31, 2019 | 82.61% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
8.88%
Minimum
Jun 2020
97.38%
Maximum
Sep 2022
53.65%
Average
60.33%
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 80.00% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 68.19% |
| Protalix BioTherapeutics Inc | 30.58% |